Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1147 results for "fda"

FDA OKs 1st biosimilar drug
CBS News

FDA OKs 1st biosimilar drug

On Friday, the Food and Drug Administration approved what's called a biosimilar version of the cancer drug Neupogen. A recent study estimates biosimilar drugs could save Americans $44 billion dollars over the next ten years. Joseph Manghan, 20, ... CBS News, 49 minutes ago
FDA approves 1st biosimilar drug Austin American Statesman, 56 minutes ago
CBS Health: FDA approves 1st biosimilar drug CBS News, 32 minutes ago

2,010 images for fda

NBCNews.com, 8 hours ago
Monthly Prescribing Reference, 10 hours ago
Long Island Business News, 5 hours ago
Drug Watch, 1 day ago
Monthly Prescribing Reference, 5 hours ago
MassDevice, 11 hours ago
Cancernetwork.com, 6 hours ago
OncLive, 7 hours ago
Examiner.com, 1 day ago
NPR, 8 hours ago

FDA approves knockoff of Amgen's Neupogen chemo recovery drug

Amgen Inc., the Thousand Oaks biotech giant, has for decades sold some of the nation's top-selling drugs with little competition. That ended Friday as the FDA approved a competitor's knockoff version of Amgen's chemotherapy recovery drug, ...
 Los Angeles Times40 minutes ago

FDA Approves New Antifungal Cresemba

 Medscape2 hours ago Astellas' antifungal Cresemba approved by FDA for invasive aspergillosis, invasive mucormycosis  FirstWord Pharma4 hours ago Astellas Receives FDA Approval for CRESEMBA┬« (isavuconazonium sulfate) for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis  Vision Monday4 hours ago FDA approves new antifungal drug Cresemba  Mr Top Step7 hours ago
[x]  

ASBM Commends FDA For Approval, Clear Naming Of First Biosimilar

Reddit Email Print Reprint WASHINGTON , March 6, 2015 /PRNewswire-USNewswire/ -- The Alliance for Safe Biologic Medicines today commended the U.S. Food and Drug Administration (FDA) on its approval of the first biosimilar to be available for ...
 TheStreet.com2 hours ago
[x]  
Examiner.com

Bristol Myers Squibb : BMS' cancer drug Opdivo gets FDA approval to treat NSCLC

The US Food and Drug Administration (FDA) has granted approval for Bristol-Myers Squibb's (BMS) Opdivo (nivolumab) injection, for intravenous use, to treat patients with metastatic squamous non-small cell lung cancer (NSCLC) with progression on or ...
 4 Traders12 hours ago Bristol-Myers: FDA Expands Approval Of Opdivo To Treat Lung Cancer  RTTNews.com2 days ago Immunotherapy lung cancer drug Opdivo receives FDA approval  Examiner.com1 day ago FDA expands approval of innovative Bristol-Myers drug for use against lung cancer  FOXBusiness.com2 days ago
[x]  
NPR

American Autoimmune Related Diseases Association's Statement on FDA's Approval of First U.S. Biosimilar Drug

American Autoimmune Related Diseases Association's Statement on FDA's Approval of First U.S. Biosimilar Drug The American Autoimmune Related Diseases Association (AARDA), a national nonprofit health organization dedicated to increasing awareness of ...
 Infrosoft3 hours ago FDA Approves First Copy of a Biotech Drug  Wall Street Journal UK6 hours ago FDA Approves First Of New Type Of Generic Drugs  NPR8 hours ago AFP - US-Switzerland-pharma-biotechnology-cancer-regulation-FDA  Namibia Press Agency8 hours ago
[x]  
Reuters UK

FDA OKs Cresemba, Astellas drug for rare but serious fungal infections, after priority review

TRENTON, N.J. The drug was approved under the FDA's designation as a Qualified Infectious Disease Product. Drugs for treating fungal and bacterial infections that receive the designation get expedited review and five years of extra market ...
 FOXBusiness.com4 hours ago U.S. FDA approves Astellas drug for invasive fungal infections  Reuters6 hours ago Astellas bags FDA approval for a new anti-infective  FierceBiotech6 hours ago FDA approves Astellas drug for serious fungal infections  Yahoo! UK and Ireland5 hours ago
[x]  
TheStreet.com

Novartis (NVS) Stock Fell Today Despite FDA Approval of Zarxio Treatment

Reddit Email Print Reprint NEW YORK ( TheStreet ) -- Novartis AG ( NVS - Get Report ) shares closed trading down $1.51% to $97.46 on Friday despite the company'swhite blood cell-boosting treatment Zarxio receiving FDA approval as the first ...
 TheStreet.com4 hours ago Amgen (AMGN) Stock Falls Today Following FDA's Approval of First 'Biosimilar' Drug  TheStreet.com10 hours ago

FDA norms will help beef stalls maintain better hygiene: Bepari

Welcoming the move of FDA to make it mandatory for the beef stalls to obtain the FDA licence, vice president of Qureshi's Meat Traders Association of Goa Manna Bepari says in an interview with Abdul Wahab Khan that adhering to the FDA norms will ...
 Navhind Times3 hours ago
Medical Design Online

FDA: Olympus Failed To Get Clearance For Scopes Linked To Superbug Outbreak

By Jof Enriquez The U.S. Food and Drug Administration (FDA) recently disclosed that the manufacturer of the duodenoscopes implicated in the superbug infection at UCLA did not receive clearance to sell the devices. According to a CNN report ...
 Medical Design Online5 hours ago FDA says maker of endoscope linked to 'superbug' outbreak did not seek federal approval  FOXBusiness.com1 day ago Maker of Device in 'Superbug' Outbreak Lacked FDA Clearance  ABC News1 day ago New superbug outbreak tied to endoscope devices surfaces amid FDA scrutiny  FierceMedicalDevices1 day ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - fda
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less